Policy | March 22, 2022
Mandaviya launches BRICS vaccine R&D centre
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
Subscribe To Our Newsletter & Stay Updated
